Concepedia

Dansu Li

DL

12

Publications

489

Citations

12

H-Index

2000

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Dartmouth College

University of California, San Francisco

Dansu Li is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

2000–2018

12

Publications

12

Small Molecules Co-targeting CKIα and the Transcriptional Kinases CDK7/9 Control AML in Preclinical Models

Waleed Minzel, Avanthika Venkatachalam, Avner Fink et al. · Cell · 2018 · 148 citations · Full text

, , +10

Key regulatory oxysterols in liver: analysis as Δ4-3-ketone derivatives by HPLC and response to physiological perturbations

Zhe Zhang, Dansu Li, Daniel E. Blanchard et al. · Journal of Lipid Research · 2001 · 74 citations · Full text

Discovery and SAR of hydantoin TACE inhibitors

Wensheng Yu, Zhuyan Guo, Peter Orth et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 56 citations · Full text

, , +5

The discovery of novel tartrate-based TNF-α converting enzyme (TACE) inhibitors

K Rösner, Zhuyan Guo, Peter Orth et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 28 citations · Full text

, , +9

Discovery of MK-3697: A selective orexin 2 receptor antagonist (2-SORA) for the treatment of insomnia

Anthony J. Roecker, Thomas S. Reger, M. Christa Mattern et al. · Bioorganic & Medicinal Chemistry Letters · 2014 · 28 citations · Full text

, , +8

Rows per page

1–5 of 12